Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: Calpain inhibition provides functional neuroprotection

Glutamate toxicity has been implicated in cell death in neurodegenerative diseases and injuries. Glutamate‐induced Ca2+ influx may mediate activation of calpain, a Ca2+‐dependent cysteine protease, which in turn may degrade key cytoskeletal proteins. We investigated glutamate‐mediated apoptosis of VSC4.1 motoneurons and functional neuroprotection by calpain inhibition. Exposure of VSC4.1 cells to 10 μM glutamate for 24 hr caused significant increases in intracellular free [Ca2+], as determined by fura‐2 assay. Pretreatment of cells with 10 or 25 μM calpeptin (a cell‐permeable calpain‐specific inhibitor) for 1 hr prevented glutamate‐induced Ca2+ influx. Western blot analyses showed an increase in Bax:Bcl‐2 ratio, release of cytochrome c from mitochondria, and calpain and caspase‐3 activities during apoptosis. Cell morphology, as evaluated by Wright staining, indicated predominantly apoptotic features following glutamate exposure. ApopTag assay further substantiated apoptotic features morphologically as well as biochemically. Our data showed that calpeptin mainly prevented calpain‐mediated proteolysis and apoptosis and maintained whole‐cell membrane potential, indicating functional neuroprotection. The results imply that calpeptin may serve as a therapeutic agent for preventing motoneuron degeneration, which occurs in amyotrophic lateral sclerosis and spinal cord injury. In this investigation, we also examined glutamate receptor subtypes involved in the initiation of apoptosis in VSC4.1 cells following exposure to glutamate. Our results indicated that the N‐methyl‐D‐aspartate (NMDA) receptors contributed more than α‐amino‐3‐hydroxy‐5‐methyl‐isoxazole‐4‐propionic acid (AMPA) receptors to glutamate‐mediated Ca2+ influx and cell death mechanism. Inhibition of the activities of both NMDA and AMPA receptors protected VSC4.1 cells from glutamate toxicity and preserved whole‐cell membrane potential. © 2005 Wiley‐Liss, Inc.

[1]  N. Banik,et al.  Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities , 2004, Molecular Cancer.

[2]  E. Sribnick,et al.  17β‐estradiol attenuates glutamate‐induced apoptosis and preserves electrophysiologic function in primary cortical neurons , 2004 .

[3]  K. Luettich,et al.  Retraction: TGFβ1 activates c-Jun and Erk1 via aVβ6 integrin , 2004, Molecular Cancer.

[4]  E. Sribnick,et al.  Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury , 2003, Journal of Chemical Neuroanatomy.

[5]  E. Hogan,et al.  Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors , 2003, Brain Research Reviews.

[6]  R. Schnellmann,et al.  Cytoprotective properties of novel nonpeptide calpain inhibitors in renal cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[7]  C. Jatzke,et al.  Voltage and concentration dependence of Ca2+ permeability in recombinant glutamate receptor subtypes , 2002 .

[8]  E. Hall,et al.  The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. , 2001, Journal of neurotrauma.

[9]  B. Pike,et al.  Concurrent Assessment of Calpain and Caspase-3 Activation after Oxygen–Glucose Deprivation in Primary Septo-Hippocampal Cultures , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  E. Hogan,et al.  Cell Death in Spinal Cord Injury (SCI) Requires de Novo Protein Synthesis , 2001, Annals of the New York Academy of Sciences.

[11]  Y. Oh,et al.  Cleavage of Bax is mediated by caspase‐dependent or ‐independent calpain activation in dopaminergic neuronal cells: protective role of Bcl‐2 , 2001, Journal of neurochemistry.

[12]  E. Marra,et al.  Glutamate neurotoxicity, oxidative stress and mitochondria , 2001, FEBS letters.

[13]  E. Ziff,et al.  Role of NMDA receptor functional domains in excitatory cell death , 2000, Neuropharmacology.

[14]  E. Hogan,et al.  Increased Calpain Expression Is Associated with Apoptosis in Rat Spinal Cord Injury: Calpain Inhibitor Provides Neuroprotection , 2000, Neurochemical Research.

[15]  G. Pons,et al.  Aspirin induces apoptosis through mitochondrial cytochrome c release , 2000, FEBS letters.

[16]  P. Sheard,et al.  Changes in mitochondrial membrane potential during staurosporine‐induced apoptosis in Jurkat cells , 2000, FEBS letters.

[17]  E. Hogan,et al.  E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats , 2000, Brain Research.

[18]  G. Cole,et al.  Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.

[19]  A. Rami,et al.  μ-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage , 2000, Brain Research.

[20]  T. Jay,et al.  Excitotoxicity in neurological disorders — the glutamate paradox , 2000, International Journal of Developmental Neuroscience.

[21]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[22]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[23]  A Büki,et al.  Cytochrome c Release and Caspase Activation in Traumatic Axonal Injury , 2000, The Journal of Neuroscience.

[24]  M. Fehlings,et al.  Pretreatment with Calpain Inhibitor CEP‐4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury , 2000, Journal of neurochemistry.

[25]  T. Shearer,et al.  Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina , 2000, Current eye research.

[26]  E. Hogan,et al.  Calpeptin and Methylprednisolone Inhibit Apoptosis in Rat Spinal Cord Injury , 1999, Annals of the New York Academy of Sciences.

[27]  Leif Hertz,et al.  Astrocytes: Glutamate producers for neurons , 1999, Journal of neuroscience research.

[28]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[29]  E. Hogan,et al.  Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells , 1999, Brain Research.

[30]  A. Doble.  The role of excitotoxicity in neurodegenerative disease: implications for therapy. , 1999 .

[31]  C. Epstein,et al.  Reduced mitochondrial manganese-superoxide dismutase activity exacerbates glutamate toxicity in cultured mouse cortical neurons , 1998, Brain Research.

[32]  T. Suuronen,et al.  Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells. , 1998, Brain Research. Molecular Brain Research.

[33]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[34]  R. Talanian,et al.  Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells* , 1998, The Journal of Biological Chemistry.

[35]  R. Nixon,et al.  Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death. , 1998, Brain research. Molecular brain research.

[36]  S. Lipton,et al.  Enhanced neuronal death from focal ischemia in AMPA-receptor transgenic mice. , 1997, Brain research. Molecular brain research.

[37]  K. Wang,et al.  Calpains mediate calcium and chloride influx during the late phase of cell injury. , 1997, The Journal of pharmacology and experimental therapeutics.

[38]  G. Cortopassi,et al.  mtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. , 1997, Biochemical and biophysical research communications.

[39]  J. Jordán,et al.  Role of Calpain‐ and Interleukin‐1β Converting Enzyme‐Like Proteases in the β‐Amyloid‐Induced Death of Rat Hippocampal Neurons in Culture , 1997 .

[40]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[41]  D. H. Burgess,et al.  Involvement of cellular proteolytic machinery in apoptosis. , 1997, Biochemical and biophysical research communications.

[42]  R. Gilbertsen,et al.  Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. , 1996, The Biochemical journal.

[43]  R. Bartus,et al.  Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[45]  R. Bartus,et al.  Calpain Inhibitor AK295 Protects Neurons From Focal Brain Ischemia: Effects of Postocdusion Intra-arterial Administration , 1994, Stroke.

[46]  E. Stefani,et al.  Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Stefani,et al.  A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  G. Lynch,et al.  Inhibition of proteolysis protects hippocampal neurons from ischemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W Singer,et al.  Excitatory amino acid receptors and synaptic plasticity. , 1990, Trends in pharmacological sciences.

[50]  S. Ozawa,et al.  Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. , 1990, The Journal of physiology.

[51]  S N Davies,et al.  Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. , 1988, Science.

[52]  T. Tsujinaka,et al.  Synthesis of a new cell penetrating calpain inhibitor (calpeptin). , 1988, Biochemical and biophysical research communications.

[53]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[54]  J. Watkins,et al.  Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord , 1982, Brain Research.

[55]  J. R. Monck,et al.  Measurement of intracellular free calcium to investigate receptor-mediated calcium signaling. , 1990, Methods in enzymology.